Chapter
Chapter II: The Malaria Parasite and Its Life Cycle
Brief Insight into Plasmodium Genome
Metabolomics in Malaria Research
Chapter III: Recent Advances in the Epidemiology of Human Malaria
Polymerase Chain Reaction
Use of Molecular Technique for Malaria Parasite Detection
Differentiate Recrudescence from Reinfection
Chapter IV: Pathogenesis and Clinical Features of Malaria Infection
Malaria Parasite and Human Immune System
Immune Evasion in Malaria Infection
Severe Malarial Anemia (SMA)
Can Automated Red Blood Cell (RBC) Be Used for Treating Severe Plasmodium falciparum Malaria?
Examples of RDT Available
CareStart Malaria Tm (AccessBio Inc)
VIKIA Malaria Ag Pf/panTM
SD Malaria Antigen Malaria Pf 05FK90-02-0 (HRP2/PLDH)
Chapter V: Update in Malaria Treatment and Resistance
Pharmacological Properties of Antimalarial Drugs
Overview of Main Drug Classes
Clinical Pharmacokinetics
Formulation of ACT Available
Limitation of Artemisinins
Mechanism of Drug Resistance
Techniques in Identifying Resistance
Management of Drug Resistance
Stages of Drug Development
New Drugs and Novel Strategies in the Pipeline
Chapter VI: Malaria Control
Economic and Social Burden of Malaria
Can We Eradicate Malaria?
Global Warming and Malaria
Treating Asymptomatic Carriers
Intermittent Presumptive Treatment (IPT) in Pregnancy
Affordable Medicine Facility
Insecticide Treated Net Beds (ITNS)
The T3: Test. Treat. Track
Controlling Imported Malaria
Circumsporozoite protein (CS)
Liver Stage Antigen 1 (LSA1)
Merozoite and Erythrocytic Antigen
Erythrocyte Binding Antigen 175 (EBA-175)
Merozoite Surface Protein 1 (MSP 1)
Apical Membrane Antigen 1 (AMA1)
Serine Repeat Antigen (SERA)
Transmission-Blocking and Pathogenicity Antigen
Malaria Vaccine in Clinical Trials
Conclusion: Future of Malaria
JOURNEY THROUGH THE WORLD OF MALARIA
JOURNEY THROUGH THE WORLD OF MALARIA
Library of Congress Cataloging-in-Publication Data
Chapter I: Introduction: History and Classification
Evolution of Malaria Parasite
Glucose-6-Phosphate Deficiency
Where, When and How Did Malaria Evolved?
Chapter II: The Malaria Parasite and Its Life Cycle
Brief Insight into Plasmodium Genome
Metabolomics in Malaria Research
Chapter III: Recent Advances in the Epidemiology of Human Malaria
Polymerase Chain Reaction
Use of Molecular Technique for Malaria Parasite Detection
Differentiate Recrudescence from Reinfection
Chapter IV: Pathogenesis and Clinical Features of Malaria Infection
Malaria Parasite and Human Immune System
Immune Evasion in Malaria Infection
Severe Malarial Anemia (SMA)
Can Automated Red Blood Cell (RBC) Be Used for Treating Severe Plasmodium falciparum Malaria?
Examples of RDT Available
CareStart Malaria Tm (AccessBio Inc)
VIKIA Malaria Ag Pf/panTM
SD Malaria Antigen Malaria Pf 05FK90-02-0 (HRP2/PLDH)
Chapter V: Update in Malaria Treatment and Resistance
Pharmacological Properties of Antimalarial Drugs
Overview of Main Drug Classes
Clinical Pharmacokinetics
Formulation of ACT Available
Limitation of Artemisinins
Mechanism of Drug Resistance
Techniques in Identifying Resistance
Management of Drug Resistance
Stages of Drug Development
New Drugs and Novel Strategies in the Pipeline
Chapter VI: Malaria Control
Economic and Social Burden of Malaria
Can We Eradicate Malaria?
Global Warming and Malaria
Treating Asymptomatic Carriers
Intermittent Presumptive Treatment (IPT) in Pregnancy
Affordable Medicine Facility
Insecticide Treated Net Beds (ITNS)
The T3: Test. Treat. Track
Controlling Imported Malaria
Circumsporozoite protein (CS)
Liver Stage Antigen 1 (LSA1)
Merozoite and Erythrocytic Antigen
Erythrocyte Binding Antigen 175 (EBA-175)
Merozoite Surface Protein 1 (MSP 1)
Apical Membrane Antigen 1 (AMA1)
Serine Repeat Antigen (SERA)
Transmission-Blocking and Pathogenicity Antigen
Malaria Vaccine in Clinical Trials
Conclusion: Future of Malaria
Journey through the World of Malaria
( Allergies and Infectious Diseases )
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.